Literature DB >> 32191539

Diagnosis-to-Ablation Time and Recurrence of Atrial Fibrillation Following Catheter Ablation: A Systematic Review and Meta-Analysis of Observational Studies.

Derek S Chew1, Eric Black-Maier1, Zak Loring1, Peter A Noseworthy2, Douglas L Packer2, Derek V Exner3, Daniel B Mark1, Jonathan P Piccini1,4.   

Abstract

BACKGROUND: The optimal timing of catheter ablation for atrial fibrillation (AF) in reference to the time of diagnosis is unknown. We sought to assess the impact of the duration between first diagnosis of AF and ablation, or diagnosis-to-ablation time (DAT), on AF recurrence following catheter ablation.
METHODS: We conducted a systematic electronic search for observational studies reporting the outcomes associated with catheter ablation for atrial fibrillation stratified by diagnosis-to-ablation time. The primary meta-analysis using a random effects model assessed AF recurrence stratified by DAT ≤1 year versus >1 year. A secondary analysis assessed outcomes stratified by DAT ≤3 years versus >3 years.
RESULTS: Of the 632 screened studies, 6 studies met inclusion criteria for a total of 4950 participants undergoing AF ablation for symptomatic AF. A shorter DAT ≤1 year was associated with a lower relative risk of AF recurrence compared with DAT >1 year (relative risk, 0.73 [95% CI, 0.65-0.82]; P<0.001). Heterogeneity was moderate (I2=51%). When excluding the one study consisting of only patients with persistent AF, the heterogeneity improved substantially (I2=0%, Cochran's Q P=0.55) with a similar estimate of effect (relative risk, 0.78 [95% CI, 0.71-0.85]; P<0.001).
CONCLUSIONS: Shorter duration between time of first AF diagnosis and AF ablation is associated with an increased likelihood of ablation procedural success. Additional study is required to confirm these results and to explore implementation of earlier catheter AF ablation and patient outcomes within the current AF care pathway. Visual Overview A visual overview is available for this article.

Entities:  

Keywords:  atrial fibrillation; catheter ablation; recurrence; risk; systematic review

Mesh:

Year:  2020        PMID: 32191539      PMCID: PMC7359927          DOI: 10.1161/CIRCEP.119.008128

Source DB:  PubMed          Journal:  Circ Arrhythm Electrophysiol        ISSN: 1941-3084


  30 in total

1.  The comparison of percentages in matched samples.

Authors:  W G COCHRAN
Journal:  Biometrika       Date:  1950-12       Impact factor: 2.445

2.  Clinical significance of early atrial arrhythmia type and timing after single ring isolation of the pulmonary veins.

Authors:  Chrishan Joseph Nalliah; Toon Wei Lim; Eddy Kizana; Pierre Qian; Pramesh Kovoor; Aravinda Thiagalingam; David Leslie Ross; Stuart Phillip Thomas
Journal:  Europace       Date:  2015-05-02       Impact factor: 5.214

3.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.

Authors:  Craig T January; L Samuel Wann; Joseph S Alpert; Hugh Calkins; Joaquin E Cigarroa; Joseph C Cleveland; Jamie B Conti; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Katherine T Murray; Ralph L Sacco; William G Stevenson; Patrick J Tchou; Cynthia M Tracy; Clyde W Yancy
Journal:  Circulation       Date:  2014-03-28       Impact factor: 29.690

4.  Diagnosis-to-ablation time in atrial fibrillation: A modifiable factor relevant to clinical outcome.

Authors:  Felipe Bisbal; Francisco Alarcón; Angel Ferrero-De-Loma-Osorio; Juan Jose González-Ferrer; Concepción Alonso-Martín; Marta Pachón; Ermengol Vallés; Pilar Cabanas-Grandío; Manuel Sanchez; Eva Benito; Axel Sarrias; Ricardo Ruiz-Granell; Julián Pérez-Villacastín; Xavier Viñolas; Miguel Angel Arias; Julio Martí-Almor; Enrique García-Campo; Ignacio Fernández-Lozano; Roger Villuendas; Lluís Mont
Journal:  J Cardiovasc Electrophysiol       Date:  2019-06-06

Review 5.  Extracellular matrix alterations in the atria: insights into the mechanisms and perpetuation of atrial fibrillation.

Authors:  Christos A Goudis; Eleftherios M Kallergis; Panos E Vardas
Journal:  Europace       Date:  2012-01-10       Impact factor: 5.214

Review 6.  Molecular and Cellular Mechanisms of Atrial Fibrosis in Atrial Fibrillation.

Authors:  Stanley Nattel
Journal:  JACC Clin Electrophysiol       Date:  2017-05-15

Review 7.  A Systematic Review on the Progression of Paroxysmal to Persistent Atrial Fibrillation: Shedding New Light on the Effects of Catheter Ablation.

Authors:  Riccardo Proietti; Alexios Hadjis; Ahmed AlTurki; George Thanassoulis; Jean-François Roux; Atul Verma; Jeff S Healey; Martin L Bernier; David Birnie; Stanley Nattel; Vidal Essebag
Journal:  JACC Clin Electrophysiol       Date:  2015-05-13

8.  Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study.

Authors:  Nassir F Marrouche; David Wilber; Gerhard Hindricks; Pierre Jais; Nazem Akoum; Francis Marchlinski; Eugene Kholmovski; Nathan Burgon; Nan Hu; Lluis Mont; Thomas Deneke; Mattias Duytschaever; Thomas Neumann; Moussa Mansour; Christian Mahnkopf; Bengt Herweg; Emile Daoud; Erik Wissner; Paul Bansmann; Johannes Brachmann
Journal:  JAMA       Date:  2014-02-05       Impact factor: 56.272

9.  Radiofrequency Ablation of Persistent Atrial Fibrillation: Diagnosis-to-Ablation Time, Markers of Pathways of Atrial Remodeling, and Outcomes.

Authors:  Ayman A Hussein; Walid I Saliba; Amr Barakat; Mohammed Bassiouny; Mohammed Chamsi-Pasha; Rasha Al-Bawardy; Ali Hakim; Khaldoun Tarakji; Bryan Baranowski; Daniel Cantillon; Thomas Dresing; Patrick Tchou; David O Martin; Niraj Varma; Mandeep Bhargava; Thomas Callahan; Mark Niebauer; Mohamed Kanj; Mina Chung; Andrea Natale; Bruce D Lindsay; Oussama M Wazni
Journal:  Circ Arrhythm Electrophysiol       Date:  2016-01

10.  Temporal trends in atrial fibrillation recurrence rates after ablation between 2005 and 2014: a nationwide Danish cohort study.

Authors:  Jannik Langtved Pallisgaard; Gunnar Hilmar Gislason; Jim Hansen; Arne Johannessen; Christian Torp-Pedersen; Peter Vibe Rasmussen; Morten Lock Hansen
Journal:  Eur Heart J       Date:  2018-02-07       Impact factor: 29.983

View more
  12 in total

Review 1.  Racial, ethnic, and sex disparities in atrial fibrillation management: rate and rhythm control.

Authors:  Sofia E Gomez; Muhammad Fazal; Julio C Nunes; Shayena Shah; Alexander C Perino; Sanjiv M Narayan; Kamala P Tamirisa; Janet K Han; Fatima Rodriguez; Tina Baykaner
Journal:  J Interv Card Electrophysiol       Date:  2022-10-13       Impact factor: 1.759

2.  Rhythm Control of Persistent Atrial Fibrillation in Systolic Heart Failure: A Bayesian Network Meta-Analysis of Randomized Controlled Trials.

Authors:  Dibbendhu Khanra; Saurabh Deshpande; Anindya Mukherjee; Siddhratha Mohan; Hassan Khan; Sanjeev Kathuria; Danesh Kella; Deepak Padmanabhan
Journal:  Int J Heart Fail       Date:  2021-06-11

3.  Efficacy of Cryoballoon Ablation for Atrial Fibrillation and Recurrence Predictors in an Asian Cohort.

Authors:  Shang-Ju Wu; Cheng-Hung Li; Chi-Jen Weng; Jiunn-Cherng Lin; Yu-Shan Chien; Yi-Huei Chen; Ching-Heng Lin; Yu-Cheng Hsieh; Jin-Long Huang; Li-Wei Lo; Yenn-Jiang Lin; Shih-Ann Chen
Journal:  J Pers Med       Date:  2022-04-30

4.  Safety and efficacy of cryoballoon ablation for the treatment of paroxysmal and persistent AF in a real-world global setting: Results from the Cryo AF Global Registry.

Authors:  Kyoung Ryul Julian Chun; Ken Okumura; Fernando Scazzuso; Young Keun On; Fred J Kueffer; Kendra M Braegelmann; Surinder Kaur Khelae; Fawzia Al-Kandari; Csaba Földesi
Journal:  J Arrhythm       Date:  2021-01-25

5.  Socioeconomic and geographic differences in ablation of atrial fibrillation in Norway - a national cohort study.

Authors:  Frank Olsen; Bård Uleberg; Bjarne K Jacobsen; Ivar Heuch; Pål M Tande; Einar Bugge; Lise Balteskard
Journal:  BMC Public Health       Date:  2022-02-14       Impact factor: 4.135

6.  Diagnosis-to-ablation time predicts recurrent atrial fibrillation and rehospitalization following catheter ablation.

Authors:  Derek S Chew; Kelley A Jones; Zak Loring; Eric Black-Maier; Peter A Noseworthy; Derek V Exner; Douglas L Packer; Jennifer Grant; Daniel B Mark; Jonathan P Piccini
Journal:  Heart Rhythm O2       Date:  2021-11-19

7.  Efficacy and safety of cryoballoon pulmonary vein isolation for paroxysmal and persistent atrial fibrillation: A comparison with radiofrequency ablation.

Authors:  Ji-Hoon Choi; Seung-Jung Park; Kyoung-Min Park; June Soo Kim; Young Keun On
Journal:  PLoS One       Date:  2022-07-27       Impact factor: 3.752

8.  Catheter Ablation as First-Line Therapy in the Treatment of Atrial Fibrillation - Should We Always Indicate it?

Authors:  Luiz Eduardo Montenegro Camanho; Gustavo Vignoli Dos Santos
Journal:  Arq Bras Cardiol       Date:  2022-07       Impact factor: 2.667

9.  Catheter ablation and healthcare utilization and cost among patients with paroxysmal versus persistent atrial fibrillation.

Authors:  Daniel J Friedman; Michael E Field; Motiur Rahman; Laura Goldstein; Qun Sha; M Sidharth; Rahul Khanna; Jonathan P Piccini
Journal:  Heart Rhythm O2       Date:  2020-12-15

10.  Catheter Ablation vs. Anti-Arrhythmic Drugs as First-Line Treatment in Symptomatic Paroxysmal Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.

Authors:  Andrea Saglietto; Fiorenzo Gaita; Roberto De Ponti; Gaetano Maria De Ferrari; Matteo Anselmino
Journal:  Front Cardiovasc Med       Date:  2021-05-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.